Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Tiopronin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,162Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    US Launch Of Venxxiva For Cystinuria Treatment
    US Launch Of Venxxiva For Cystinuria Treatment

    18 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250310346821/en/New-US-product-launch-VENXXIVA-tiopronin-Delayed-Release-Tablets-for-the-treatment-of-cystinuria

    BUSINESSWIRE
    18 Mar 2025
    Share Share
    Teva Pharma's Generics Tiopronin Receives Approval in US
    Teva Pharma's Generics Tiopronin Receives Approval in US

    22 Jul 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216456

    FDA
    22 Jul 2024
    Share Share
    Pharma is Missing the Mark: Social Media's Power Proven by Physician Influencers
    Pharma is Missing the Mark: Social Media's Power Proven by Physician Influencers

    15 Jul 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/pharma-is-missing-the-mark-social-medias-power-proven-by-physician-influencers-302196387.html

    PR NEWSWIRE
    15 Jul 2024
    Share Share
    New Tiopronin Delayed-Release Tablets Launch With US Patient Support
    New Tiopronin Delayed-Release Tablets Launch With US Patient Support

    13 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240510381242/en

    BUSINESSWIRE
    13 May 2024
    Share Share
    Amneal's Generic Tiopronin Receives Approval in the U.S.
    Amneal's Generic Tiopronin Receives Approval in the U.S.

    15 Aug 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216278

    FDA
    15 Aug 2023
    Share Share
    FDA Confirms Paragraph IV Patent Litigation for Tiopronin Tablets
    FDA Confirms Paragraph IV Patent Litigation for Tiopronin Tablets

    14 Dec 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-tiopronin-tablets-53026.pdf

    FDA
    14 Dec 2022
    Share Share